ARC provides patients and healthcare professionals with the latest, up-to-date resources to
help improve treatment and care of patients with amyloidosis.
ARC Cardiac Amyloidosis Survey: Results from AL Patients and Caregivers
Amyloidosis Research Consortium Cardiac Amyloidosis Survey: Results from Patients with AL Amyloidosis and Their Caregivers, was presented at the European Hematology Association (EHA) 22nd Annual Congress from June 22 - 25, 2017 in Madrid, Spain. This poster captures results from 137 AL amyloidosis patients and caregivers to help understand the difficult diagnostic journey and experiences of AL amyloidosis patients.Download
Guidance for Industry AL Amyloidosis – Developing Drugs for Industry
Developing the guidance involved active participation from all stakeholder groups including patients, medical experts, academics and biopharmaceutical industry representatives. This guidance has been submitted to FDA.Download
ARC Clinical Resources APP
Learn how this valuable tool developed by ARC is giving healthcare professionals easy access to critical and current medical information and improving diagnosis.Visit Website